
· Executive Brief
National ADHD Awareness Month 2026
A practical executive framework for access, ownership, handoffs, measurement, and improvement.

Leadership signal
National ADHD Awareness Month can serve as an executive operating checkpoint.
Awareness can generate questions and requests for help. Executive teams can prepare by clarifying the first point of contact, the qualified team that accepts the request, the handoff standard, and the method used to verify completion without assuming that one route fits every person.
Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.
Executive opening
ADHD care is a lifespan pathway with predictable break points
Attention-deficit/hyperactivity disorder reaches health systems through many doors: pediatric practices, school referrals, adult primary care, behavioral health clinics, community pharmacies and online video feeds. Among U.S. children aged 3 to 17 in 2016 to 2019, state-level estimates of diagnosed ADHD ranged from 6.1% to 16.3%.[13] Among U.S. working-age adults aged 18 to 64, 13.9% self-reported in 2023 that a health care professional had ever diagnosed them with ADHD.[6] Demand of that size and spread cannot be managed by one service line or one age group.
The operating risk sits at the junctions between services. A British national surveillance study followed young people with ADHD reaching the boundary between child and adult services.[14] Of these, 64% had their referral accepted, but only 22% attended a first appointment, and only 6% met optimal transition criteria.[14] During the prescription stimulant shortage, people with ADHD described significant difficulty obtaining medication, and some sought it through unofficial channels.[8] Adult treatment capacity is also thin: among 12,898 providers in a national telepsychology directory reviewed in April 2025, only 26.4% explicitly offered any services for adult ADHD.[3]
None of these gaps belongs to a single clinic. They reflect how diagnosis, prescribing, dispensing, school coordination and adult follow-up are linked across organizations, or left unlinked. National ADHD Awareness Month gives executives a reason to examine those links with the same discipline they apply to other chronic conditions that begin in childhood and continue into adult life.
The sections below summarize current peer-reviewed evidence on burden, continuity, access, equity, workforce and public communication. They sit beside the executive guidance already on this page and give boards and operating leaders a shared factual base for deciding where to act first and what to measure once they do.
Current evidence
What the research says about burden, variation and risk
Childhood ADHD is common, but how often it is diagnosed and treated depends heavily on where a child lives. A national parent survey covering 114,476 children aged 3 to 17 in 2016 to 2019 produced state-level estimates of diagnosed ADHD that ranged from 6.1% to 16.3%.[13] Among children with current ADHD, state-level estimates of medication use ranged from 37.8% to 81.4%, and estimates of behavioral treatment ranged from 38.8% to 61.8%.[13] The authors presented these results as a resource for policymakers, public health practitioners and health care providers working to address the service needs of children with ADHD in their states.[13]
Adult demand is rising, and its true size is uncertain. In a 2023 national survey of 7,053 working-age adults, 13.9% (95% confidence interval 13.0% to 15.0%) self-reported a lifetime ADHD diagnosis.[6] That estimate was substantially higher than an estimate of 4.25% from 2012 and a 2023 estimate of 7.8% among adults of all ages.[6] The authors noted that the increase may reflect changes in diagnostic criteria for children and adults, greater acceptance of adult diagnosis, over- and mis-diagnosis, and methodological issues.[6] They described estimates drawn from online panels as provisional.[6] For capacity planning, that uncertainty argues for adult services that can flex rather than for fixed assumptions about volume.
ADHD also carries risk that shows up outside behavioral health budgets. One study used national survey data on 66,236 children from 2010 to 2019.[11] Children with ADHD had significantly higher injury prevalence than children without ADHD (odds ratio 1.20, 95% confidence interval 1.07 to 1.33).[11] The difference held across injury types and most sociodemographic subgroups.[11] The authors called for research into the mechanisms of injury disparities to inform future preventive efforts.[11] Those injuries arrive in emergency departments, urgent care centers and pediatric offices.
Medication supply has become a measurable system risk. Australian national dispensing data for 2022 to 2024 showed a constant increase in lisdexamfetamine dispensing from January 2022 to August 2023.[7] The authors considered this likely to reflect the February 2021 expansion of subsidy to patients aged 18 years and older.[7] When specific strengths went into shortage from August 2023, dispensing shifted toward other strengths, and changes in defined daily doses suggested that people likely transitioned to different strengths to maintain their dose.[7] The authors concluded that dispensing patterns must be monitored during shortages so that inequities of access can be identified and addressed.[7]
The pattern across these studies is consistent. ADHD is common in both children and adults, diagnosis and treatment vary widely by place, and supply disruptions change how people obtain treatment. The state-level survey authors offered their estimates as a tool for addressing local service needs, and the shortage analysis authors called for ongoing monitoring of dispensing patterns.[13][7]
Figure 1
ADHD care routes thin out at the adult handoff, school coordination and adult treatment capacity
Percent of the reported population or provider group reaching each step, as stated in each study’s abstract. Values are copied from the cited studies [2], [3], [14]; none is estimated.
Data note. The three transition values come from one study, but the abstract does not state whether each percentage shares the same denominator, so they are reported drop-off points rather than a strict funnel; the two provider values come from different studies, countries, years and denominators, so any comparison with the transition values is an indirect comparison.
Limitation. Each value reflects its own setting and definition; the transition figures are a lower limit because the surveillance study included only young people taking medication, and the provider figures describe stated services or self-reported coordination rather than patient outcomes.
Figure data (5 rows)
| Measure | Value | Population, setting and year as reported | Source |
|---|---|---|---|
| Referral to adult services accepted | 64% | Young people with ADHD taking medication at the child-to-adult service boundary; 12-month British national surveillance study | [14] |
| Attended a first adult-service appointment | 22% | Same British national surveillance study of young people with ADHD at the transition boundary | [14] |
| Met optimal transition criteria | 6% | Same British national surveillance study of young people with ADHD at the transition boundary | [14] |
| Child-serving primary care providers offering school intervention coordination | 23.7% | 1,047 child-serving U.S. primary care providers, survey, fall 2023 | [2] |
| Telepsychology providers explicitly offering any adult ADHD services | 26.4% | 12,898 providers in a U.S. interstate telepsychology directory, April 2025 | [3] |

Continuum of care
Where continuity breaks: treatment endings, shortages and the adult handoff
The move from child to adult services is the clearest point where ADHD care either holds or fails. A 12-month British national surveillance study estimated that, among people aged 17 to 19, the incident rate of transition need was 202 to 511 per 100,000 per year.[14] Successful transition was 38 to 96 per 100,000 per year.[14] Eligible young people were mostly male (77%) and most had a comorbid condition (62%).[14] Half were referred to specialist adult ADHD services and 25% to general adult mental health services.[14] The authors named two critical points, referral acceptance and first appointment attendance, and noted that because participants had to be taking medication, the estimates represent the lower limit of transition need.[14]
Qualitative evidence helps explain why the handoff is fragile. A systematic review of eight qualitative studies noted that up to two thirds of young people with ADHD may experience symptoms into adulthood.[15] Yet many young people with ongoing needs do not transfer from child to adult services.[15] Its themes centered on hurdles that had to be negotiated, limitations of adult mental health services, inadequate care and the impact of transition difficulties.[15] Respondents identified a need for better information about adult services and what to expect, greater flexibility around age boundaries, and support from specialist adult ADHD services.[15]
Continuity can also end well before adulthood. In a German study of 4,948 children and adolescents with an administrative ADHD diagnosis registered with their health insurer, approximately 40% were currently receiving ADHD treatment.[5] The most common reasons for not using mental health care included treatment having already ended, a lack of available treatment options and long waiting times.[5] Others were a lack of motivation among children and the inability to continue treatment because of the COVID-19 pandemic.[5] An ended episode is not necessarily a planned discharge, and executives can ask whether their own records distinguish the two and whether anyone follows up when care stops without a plan.
Shortages break continuity at the pharmacy counter. In interviews with people with ADHD directly affected by the stimulant shortage, participants described significant difficulties in accessing medication, and controls aimed at reducing non-medical use were found to make those access issues worse.[8] The Australian dispensing analysis identified potential changes in prescriber and patient behavior during shortages, such as switching to higher-strength products or using medicines intermittently, to maintain continuity of care.[7] For a health system, that makes shortage response a shared task for pharmacy, prescribers and patient communication rather than a supply chain issue alone. It places continuity of ADHD treatment on the same footing as other chronic medication programs that leaders already monitor.
Figure 3
Why the pathway breaks
People
- Primary care clinicians uncomfortable with ADHD evaluation or lacking post-degree training
- Few psychology providers offering adult ADHD services or cognitive behavioral therapy
- Caregiver mental health strain and sole-caregiver status shaping treatment decisions
Process
- Adult referrals not accepted or first adult appointments not attended
- Treatment ending without a planned next step
- School information received without direct coordination
Technology
- Misleading short-video content driving self-identification
- Dispensing not monitored by product and strength during shortages
- Remote care capacity concentrated on other conditions
Environment
- Prescription stimulant and other ADHD medication shortages
- Long waiting times and lack of available treatment options
- Stigma climates that complicate diagnosis and disclosure
Policy
- Controls on non-medical use that worsen legitimate access
- Care restricted to limited-capacity secondary or tertiary services
- Financial conflicts and rigid age boundaries that hinder transfer between services
Measurement
- Wide state-level variation not tracked against local data
- Transition counted at referral rather than at attended appointment
- Results not stratified by migration background, race, sex or insurance
Unranked qualitative cause-and-effect diagram for the outcome in the box: Children and adults with ADHD do not move reliably from first concern through diagnosis and continuous treatment to an attended adult-service appointment Causes are assembled from the cited literature [1], [2], [3], [4], [5], [7], [8], [9], [12], [13], [14], [15]; categories are not weighted and their order carries no meaning.
Data note. Qualitative; no frequencies are implied.
Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.
Figure data (6 rows)
| Category | Causes drawn from the cited literature |
|---|---|
| People | Primary care clinicians uncomfortable with ADHD evaluation or lacking post-degree training; Few psychology providers offering adult ADHD services or cognitive behavioral therapy; Caregiver mental health strain and sole-caregiver status shaping treatment decisions |
| Process | Adult referrals not accepted or first adult appointments not attended; Treatment ending without a planned next step; School information received without direct coordination |
| Technology | Misleading short-video content driving self-identification; Dispensing not monitored by product and strength during shortages; Remote care capacity concentrated on other conditions |
| Environment | Prescription stimulant and other ADHD medication shortages; Long waiting times and lack of available treatment options; Stigma climates that complicate diagnosis and disclosure |
| Policy | Controls on non-medical use that worsen legitimate access; Care restricted to limited-capacity secondary or tertiary services; Financial conflicts and rigid age boundaries that hinder transfer between services |
| Measurement | Wide state-level variation not tracked against local data; Transition counted at referral rather than at attended appointment; Results not stratified by migration background, race, sex or insurance |
Access
Access depends on capacity in primary care, behavioral health and remote care
Adults with ADHD face a narrow front door. One analysis began from the observation that at least a third of U.S. adults with ADHD do not access recommended treatments, meaning medication or cognitive behavioral therapy.[3] Those receiving treatment face barriers such as inconsistent availability of medication.[3] Among 12,898 providers listed in an interstate telepsychology directory in April 2025, only 26.4% explicitly offered any services for adult ADHD.[3] Providers were nearly three times more likely to treat adult depression (69.2%) and anxiety (74.0%).[3] Cognitive behavioral therapy for adult ADHD was offered by just 21.3% of providers.[3] The authors argued that contributors to this inequity must be identified, because untreated ADHD is a costly public health burden.[3]
Specialist capacity is a recurring structural constraint for adults. A 2024 national survey in England of 782 commissioners, health professionals and people with lived experience found that support for shared-care prescribing of adult ADHD medication in primary care was not universally available.[9] For a health system, the practical question is which parts of assessment, treatment and routine monitoring primary care could hold, and what specialist support those teams would need.
Families who do reach care often value it. In the German study, 76% of parents were satisfied with their child’s treatment and 85% considered it effective.[5] Children with more severe ADHD symptoms had a threefold higher likelihood of receiving treatment.[5] When access tracks severity this closely, children with moderate needs may be the ones left waiting, a pattern executives can test in their own referral, waitlist and treatment-start data.
Access does not end at diagnosis. A 2026 systematic review of 21 studies on adults’ lived experiences of diagnosis found that adults experienced the diagnostic process as beset by barriers and delays.[1] They reported highly variable access to post-diagnosis supports or treatment.[1] In the English survey, more than 40% of responders reported extended adult mental health service wait times of two years or longer.[9] For executives, the access question therefore covers assessment, treatment start, routine monitoring and the support that follows a new diagnosis, not only the wait for a first appointment.
Executive guidance · System route
Build one visible operating route for National ADHD Awareness Month.
Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.
The route at a glance
- Listen
- Clarify entry
- Coordinate the partner route
- Protect transitions
- Verify and learn
Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.
Listen
Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions.
Clarify entry
Publish a plain-language first step and identify who receives requests through each approved channel.
Coordinate the partner route
Align internal teams and external partners around one current message, real entry point, receiving owner, escalation path, and follow-through signal.
Protect transitions
Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations.
Verify and learn
Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals.
Figure 2
The system route as one flow
The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.
Data note. Shows sequence and handoffs only; it carries no counts or rates.
Limitation. Local processes may add, merge or reorder stages under organizational policy.
Figure data (5 rows)
| Stage | What the stage requires |
|---|---|
| Listen | Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions. |
| Clarify entry | Publish a plain-language first step and identify who receives requests through each approved channel. |
| Coordinate the partner route | Align internal teams and external partners around one current message, real entry point, receiving owner, escalation path, and follow-through signal. |
| Protect transitions | Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations. |
| Verify and learn | Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals. |
Equity and trust
Equity gaps shape who is diagnosed, who is treated and who is heard
Variation in ADHD diagnosis is not random. Among U.S. working-age adults in 2023, self-reported lifetime diagnosis varied significantly by sex, age, race and ethnicity, nativity, education and rural-urban residence.[6] Rates were higher among adults who were female, younger, non-Hispanic White, U.S.-born or less well-educated.[6] For children, state-level estimates of medication use among those with current ADHD ranged from 37.8% to 81.4%, which makes geography an equity question in its own right.[13] A health system that serves several communities can expect similar spreads inside its own footprint.
Migration background and race appear repeatedly. In the German study, youths with a migration background were less likely to receive mental health care.[5] A mixed-methods U.S. study of low-income Black caregivers was followed by an analysis of 450 Black uninsured or publicly insured children aged 6 to 17 with ADHD.[12] Medication decisions were shaped by child safety and volatility, caregiver mental health, caregiver aggravation, family-centered care, shared decision making, sole caregiver status and school involvement.[12] After adjusting for ADHD severity, previous receipt of special education services and experiences of family-centered care and shared decision making were independently associated with receipt of medication.[12] The authors concluded that clinicians and school personnel can intervene to decrease disparities in the treatment of ADHD.[12]
Sex and late diagnosis create a further gap. A systematic review of eight studies on ADHD in adult women identified four themes, namely impacts on social-emotional well-being, difficult relationships, lack of control, and self-acceptance after diagnosis.[10] It drew out implications for late diagnosis in women.[10] The 2026 review of adult diagnostic experiences found that diagnosis facilitated interpersonal understanding and communication but also exposed adults to stigma and introduced dilemmas about disclosure.[1] Experiences varied by individual biographies, interpersonal resources, stigma climates and service structures.[1]
Equity also includes parity across conditions. The telepsychology analysis concluded that U.S. psychologists, the chief providers of cognitive behavioral therapy for adult mental disorders, systemically underserve adults with ADHD.[3] Injury risk is similarly broad: the higher injury prevalence among children with ADHD held across most sociodemographic subgroups, and the authors called for work on the mechanisms of injury disparities.[11] Trust grows when an organization can show, with stratified data reviewed by its leaders, that people from every community reach diagnosis, treatment and adult follow-up at comparable rates. It also grows when the organization explains openly what it is doing where they do not.

Human infrastructure
The people who carry ADHD care across clinics, schools and pharmacies
Pediatric ADHD care depends on primary care clinicians who can evaluate, treat and coordinate with schools. In a fall 2023 survey of 1,047 child-serving U.S. primary care providers, 20.5% offered no school communication, 55.8% used school information without direct coordination, and 23.7% offered school intervention coordination.[2] Pediatricians least often reported no school communication, and nurse practitioners most often reported school intervention coordination.[2] Coordination with schools, in other words, is the exception rather than the norm, and it varies by profession.
Training needs are not uniform. Provider lack of comfort with ADHD evaluation and inadequate training after their degree were most common among providers offering no school communication.[2] Providers who used school information most often reported not needing more ADHD training.[2] Barriers such as lack of knowledge and training needs, family resistance to evaluation, worries about stigma and treatment access were most common among providers who offered school intervention coordination.[2] The authors suggested that training efforts may benefit from distinguishing providers who need foundational knowledge about ADHD care from those who already coordinate with schools and seek advanced training and support.[2]
Adult services face a capacity problem that reaches beyond specialist headcount. Guidelines in England recommend that primary care practitioners prescribe adult ADHD medication under shared-care agreements with adult mental health services.[9] Yet reported prescribing provision was 95% among health professionals versus 64% among people with lived experience.[9] Psychology capacity is a parallel constraint, given that just 21.3% of listed telepsychology providers offered cognitive behavioral therapy for adult ADHD.[3]
Transition work needs owners on both sides of the age boundary. The British surveillance study found a low rate of successful transition and limited guideline adherence, and it concluded that commissioners and service providers have a significant need to improve service transition experiences.[14] Young people, caregivers and clinicians in the qualitative transition review valued support from specialist adult ADHD services.[15] School personnel are part of this workforce too: previous receipt of special education services was independently associated with Black children’s receipt of ADHD medication in the mixed-methods study.[12] Executives can treat school liaisons, pharmacists, nurse practitioners, pediatric clinicians and adult behavioral health teams as one workforce plan for ADHD rather than as separate budgets that rarely meet.
Executive guidance · Operating dashboard
Use a small dashboard to expose friction and ownership.
Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.
Four operating signals
Each signal pairs an executive question with one candidate local measure, set out below.
Executive guidance · Signal
Entry-point clarity
Can people and staff identify the approved first step without searching across conflicting instructions?
- Candidate local measure
- Locally defined contact, routing, and repeat-contact signals by channel and service.
Executive guidance · Signal
Ownership reliability
Does a specific team accept each request and make its status visible?
- Candidate local measure
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
Executive guidance · Signal
Partner-route reliability
Do participating teams share one current route and understand who owns each dependency?
- Candidate local measure
- Locally defined conflicting instructions, unaccepted handoffs, unresolved dependencies, repeat contacts, and partner feedback.
Executive guidance · Signal
Improvement closure
Does the organization correct recurring friction and report what changed?
- Candidate local measure
- Selected barriers, assigned actions, completion status, and post-change review.
Figure 4
The operating system behind the dashboard
The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.
Data note. Structural diagram; no measured values.
Limitation. Owners are candidates to be confirmed locally.
Figure data (4 rows)
| Operating signal | Candidate owner |
|---|---|
| Entry-point clarity | Executive sponsor and operational lead |
| Ownership reliability | Operational owner and participating teams |
| Partner-route reliability | Sending and receiving owners |
| Improvement closure | Improvement owner and executive sponsor |
Executive guidance · Handoff workflow
Close the loop across teams, settings, and partners.
A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.
How responsibility moves
Lane A
From message to accepted ownership
- Confirm the approved message and intended audience.
- Publish the actual entry point and receiving role.
- Acknowledge receipt using the locally approved method.
- Escalate when ownership or response remains unclear.
Lane B
From accepted ownership to verified follow-through
- Record the next accountable owner and visible status.
- Name the sending and receiving owners, shared information, current status, and unresolved dependency.
- Keep unresolved work visible across boundaries.
- Confirm closure or document the continuing exception.
Executive guidance · Executive scorecard
Give leaders one view of route reliability and improvement.
The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.
Who reviews what
- Executive sponsor and operational lead
- Operational owner and participating teams
- Sending and receiving owners
- Improvement owner and executive sponsor
Candidate owners named in the scorecard, confirmed locally.
| Operating signal | Executive question | Candidate owner | Suggested review point |
|---|---|---|---|
| Entry-point clarity | Can people and staff identify the approved first step without searching across conflicting instructions? | Executive sponsor and operational lead | At campaign launch and close |
| Ownership reliability | Does a specific team accept each request and make its status visible? | Operational owner and participating teams | At a locally defined cadence |
| Partner-route reliability | Do participating teams share one current route and understand who owns each dependency? | Sending and receiving owners | At a locally defined cadence |
| Improvement closure | Does the organization correct recurring friction and report what changed? | Improvement owner and executive sponsor | Until action is verified |
Figure 5
Control points for a reliable ADHD access and continuity pathway
| Control point | Risk if missing | Owner | Evidence of control |
|---|---|---|---|
| Shortage continuity watch for ADHD medications | Patients go without treatment or turn to unofficial sources when supply fails | Chief pharmacy officer with ambulatory medical director | Dispensing reviewed by product and strength during shortage periods, with outreach when fills lapse |
| Accepted handoff to adult services | Referral is made but never accepted, or the first adult appointment is missed | Pediatric and adult behavioral health service leads | Share of transition referrals accepted and first adult appointments attended, tracked per young person |
| Primary care ADHD capability | Clinicians uncomfortable with evaluation defer or decline care | Chief medical officer and primary care medical director | Training matched to foundational or advanced needs, with a defined primary care monitoring role |
| Two-way school coordination | School information arrives but no one coordinates interventions | Pediatric primary care lead with school health liaison | Documented, consented school contact for children in active ADHD care |
| Adult assessment and post-diagnosis capacity | Adults wait for assessment and find little support after diagnosis | Behavioral health service line executive | Time from referral to assessment and to first post-diagnosis visit, including psychological therapy availability |
| Stratified access review | Gaps by migration background, race, sex, insurance or geography remain invisible | Chief health equity officer and board quality committee | Diagnosis, treatment and transition measures stratified and reviewed at a set cadence |
| Clinician-reviewed public information | Families and adults act on misleading online content | Chief communications officer with clinical content reviewers | Public ADHD content tested for understandability and actionability before release |
Control points derived from the cited evidence [2], [3], [4], [5], [6], [7], [8], [9], [12], [13], [14] and this brief’s executive guidance.
Data note. Each row is a control to verify, not a measured result.
Limitation. Owners and evidence of control must follow local policy and applicable requirements.
Public communication
Public communication that competes with misinformation and supports informed care
Popular online video is a source of ADHD information whose quality is uneven. A cross-sectional study of the 125 most-liked ADHD-related videos uploaded to a short-video platform between July 2021 and November 2023 rated 50.4% (63/125) as misleading, 30.4% (38/125) as personal experience and 19.2% (24/125) as useful.[4] Across all videos, understandability scored 79.5% and actionability 5.1% on a standard assessment tool for audiovisual patient education materials, and useful videos scored 92.3% for understandability.[4]
Viewers responded strongly to what they saw. In 600 sampled comments, viewers resonated with the ADHD-related behaviors shown in 220 (36.7%) and with ADHD itself in 32 (5.3%).[4] The authors warned that the high number of misleading videos and the high percentage of users who self-identify with the behaviors shown can potentially increase misdiagnosis.[4] They called for health care professionals to address misconceptions arising from these platforms.[4] That concern aligns with the adult survey authors, who listed over- and mis-diagnosis among the possible reasons for rising self-reported diagnosis.[6]
Communication inside care matters as much as public messaging. In the study of low-income Black families, experiences of family-centered care and shared decision making were independently associated with children’s receipt of ADHD medication after adjusting for severity.[12] In the transition review, young people and caregivers asked for better information about adult services and what to expect before the handoff.[15] Both findings describe communication as part of how care is delivered, not as a separate campaign.
Shortage communication needs to be honest and practical. People affected by the stimulant shortage described significant difficulties in accessing medication, and some sought it via unofficial channels.[8] Public messages during National ADHD Awareness Month can point to real, approved routes for prescription and supply problems, agreed in advance by pharmacy and prescribing leaders, rather than offering general reassurance.
Adults receiving a new diagnosis need communication that anticipates what comes next. The 2026 review found that diagnosis was widely experienced as a pivotal identity event that could foster greater self-compassion but also grief, anger and identity confusion.[1] The review of women’s experiences similarly described self-acceptance after diagnosis alongside effects on social-emotional well-being and relationships.[10] Clear, respectful information about follow-up, support options and how to ask for help is part of the service, not an add-on.

Executive guidance · 90-day plan
Turn the observance into one sustained operating change.
The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.
Ninety days, three moves
- Days 1–30See the current route
- Days 31–60Build the reliable path
- Days 61–90Make the change visible
Days 1–30 · Listen and map
See the current route
- Name an executive sponsor and an operational owner.
- Listen to people using the route and representative frontline teams.
- Map how National ADHD Awareness Month communications connect to real entry points, owners, transitions, and escalation.
- Select one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and test
Build the reliable path
- Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
- Validate the design with every sending and receiving team involved.
- Test one internal or partner handoff and correct a verified communication, dependency, or ownership gap.
- Test the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verify
Make the change visible
- Launch the redesigned route with a small set of locally defined measures.
- Review unresolved work and recurring friction using a learning approach.
- Correct implementation barriers and record who owns each remaining dependency.
- Report what changed, what evidence was reviewed, and what still requires live oversight.
Figure 6
The 90-day plan on one timeline
The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.
Data note. Time boxes are a management framework, not a clinical timeline.
Limitation. Durations are uniform 30-day windows; real tasks may span windows.
Figure data (12 rows)
| Window | Action |
|---|---|
| Days 1–30 · Listen and map | Name an executive sponsor and an operational owner. |
| Days 1–30 · Listen and map | Listen to people using the route and representative frontline teams. |
| Days 1–30 · Listen and map | Map how National ADHD Awareness Month communications connect to real entry points, owners, transitions, and escalation. |
| Days 1–30 · Listen and map | Select one recurring barrier that the organization can responsibly address. |
| Days 31–60 · Design and test | Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal. |
| Days 31–60 · Design and test | Validate the design with every sending and receiving team involved. |
| Days 31–60 · Design and test | Test one internal or partner handoff and correct a verified communication, dependency, or ownership gap. |
| Days 31–60 · Design and test | Test the route in more than one representative setting or operating period where practical. |
| Days 61–90 · Implement and verify | Launch the redesigned route with a small set of locally defined measures. |
| Days 61–90 · Implement and verify | Review unresolved work and recurring friction using a learning approach. |
| Days 61–90 · Implement and verify | Correct implementation barriers and record who owns each remaining dependency. |
| Days 61–90 · Implement and verify | Report what changed, what evidence was reviewed, and what still requires live oversight. |
Executive guidance · Leadership close
Make National ADHD Awareness Month a starting point, not an endpoint.
Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.
Leadership commitment
Make ownership visible, test the route, and report what improved.
Executive action kit · Month observance
Turn National ADHD Awareness Month into accountable action.
A practical executive framework for access, ownership, handoffs, measurement, and improvement.
Leadership focus
Use this observance to examine trustworthy information, prevention access, and community connection. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.
Workforce lens
Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the information, access, coordination, and follow-through pathway.
Patient and community lens
Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.
Equity and access lens
Review language, disability, transportation, digital access, geography, trust, and other barriers using protected feedback and locally appropriate data.
Five-minute briefing
Inspect the operating sequence
Listen with people using the pathway, frontline teams, operational leaders, and community partners. Find one a message, request, referral, or handoff that does not reach an accountable owner, then test the locally approved route from entry through acknowledged follow-through.
- Listen
- Clarify entry
- Coordinate the partner route
- Protect transitions
- Verify and learn
Leadership actions for this week
- Name an executive sponsor and frontline operating owner.
- Ask people using and operating the pathway where ownership becomes unclear.
- Test one representative route from first question to acknowledged next step.
- Select one barrier that can be corrected without overstating the evidence.
- Set a review date and define how completion will be verified.
Candidate measures
Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.
- Locally defined contact, routing, and repeat-contact signals by channel and service.
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
- Locally defined conflicting instructions, unaccepted handoffs, unresolved dependencies, repeat contacts, and partner feedback.
Department readiness checklist
- The public and staff entry points match the actual approved process.
- A specific role accepts each request, referral, or escalation.
- Handoffs include acknowledgment and a visible unresolved state.
- Language, disability, digital, transportation, and trust barriers receive explicit review.
- Communications do not introduce unsupported themes, statistics, or clinical advice.
- A named leader will review what changed after the observance.
Intended audiences
- Executive and Operational Leaders
- Public Health and Community Partners
Staff communication template
During National ADHD Awareness Month, our organization will connect awareness with a practical review of the information, access, coordination, and follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.
Community communication template
National ADHD Awareness Month is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.
Measurement worksheet
- Signal
- What observable condition will show whether the route works?
- Definition
- What is included, excluded, and counted?
- Owner
- Who reviews the signal and acts on exceptions?
- Cadence
- When will leaders review it?
- Equity check
- Which differences require protected, locally appropriate review?
- Closure
- What evidence will confirm the improvement was completed?
- Editorial review
- Completed
- Source records
- 2 listed under Authoritative resources
- Review standard
- Sourced facts remain separated from original executive guidance
- Clinical boundary
- No new statistical or clinical claim was added by this action kit
Sources and content boundary
Authoritative resources
Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.
Peer-reviewed references
References
Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .
- 1.McGill L, Jardim-Lalor I, O’Connor C. A Systematic Review of Lived Experiences of Receiving a Diagnosis of ADHD in Adulthood. Journal of Attention Disorders. 2026:online ahead of print, May 30, 2026. https://doi.org/10.1177/10870547261455946
- 2.Claussen AH, Katz SM, Newsome K, DuPaul GJ. Providers of ADHD Care for Children: Factors Associated With Coordination of ADHD Services With Schools. Journal of Attention Disorders. 2026;30(7):930-944. https://doi.org/10.1177/10870547261433741
- 3.Rout MR, Gaddis A, Yeguez CE, Sibley MH, Groves NB. Disparities in Adult ADHD Care Delivery Among U.S. Telepsychology Providers. Journal of Attention Disorders. 2026;30(5):571-576. https://doi.org/10.1177/10870547251409862
- 4.Sieferle K, Guidi T, Dorr F, Bitzer EM. Quality and Perception of Attention-Deficit/Hyperactivity Disorder Content on TikTok: Cross-Sectional Study. JMIR Infodemiology. 2025;5:e75973. https://doi.org/10.2196/75973
- 5.Kaman A, Gilbert M, Devine J, et al. Utilization of Mental Health Care Services Among Children and Adolescents with ADHD in Germany: Treatment Satisfaction and Factors Influencing Access. Journal of Attention Disorders. 2025;29(14):1307-1318. https://doi.org/10.1177/10870547251357756
- 6.London AS, Monnat SM, Gutin I. Self-Reported ADHD Diagnosis Status Among Working-Age Adults in the United States: Evidence From the 2023 National Wellbeing Survey. Journal of Attention Disorders. 2025;29(6):399-410. https://doi.org/10.1177/10870547251319861
- 7.Janetzki J, Kalisch L, Hall K, Pratt N. Utilisation Trends of Lisdexamfetamine: Insights From Recent Medicine Shortages in Australia. Pharmacoepidemiology and Drug Safety. 2025;34(2):e70113. https://doi.org/10.1002/pds.70113
- 8.Johnson B, Stjepanovic D, Leung J, Chan GCK. “Everything’s a Challenge”: An Interview Study of ADHD Individuals in the Midst of the Prescription Stimulant Shortage. Journal of Attention Disorders. 2025;29(2):120-127. https://doi.org/10.1177/10870547241288351
- 9.Price A, Becker K, Ward JH, Ukoumunne OC, Gudka R, Salimi A, et al. Support for Primary Care Prescribing for Adult ADHD in England: National Survey. British Journal of General Practice. 2024;74(748):e777-e783. https://doi.org/10.3399/bjgp.2023.0595
- 10.Attoe DE, Climie EA. Miss. Diagnosis: A Systematic Review of ADHD in Adult Women. Journal of Attention Disorders. 2023;27(7):645-657. https://doi.org/10.1177/10870547231161533
- 11.Shen J, Shi J, Gauthier L, Li W. A Population-Based Study on Injury Risk and Disparities Among Children With ADHD. Journal of Attention Disorders. 2023;27(8):859-866. https://doi.org/10.1177/10870547231158386
- 12.Glasofer A, Dingley C, Kim J, Colosimo R, Gordon HRD. Medication Decision Making in Low-Income Families of Black Children With ADHD: A Mixed Methods Study. Journal of Attention Disorders. 2023;27(8):847-858. https://doi.org/10.1177/10870547231158382
- 13.Danielson ML, Holbrook JR, Bitsko RH, et al. State-Level Estimates of the Prevalence of Parent-Reported ADHD Diagnosis and Treatment Among U.S. Children and Adolescents, 2016 to 2019. Journal of Attention Disorders. 2022;26(13):1685-1697. https://doi.org/10.1177/10870547221099961
- 14.Eke H, Ford T, Newlove-Delgado T, et al. Transition between child and adult services for young people with attention-deficit hyperactivity disorder (ADHD): findings from a British national surveillance study. The British Journal of Psychiatry. 2020;217(5):616-622. https://doi.org/10.1192/bjp.2019.131
- 15.Price A, Janssens A, Woodley AL, Allwood M, Ford T. Review: Experiences of healthcare transitions for young people with attention deficit hyperactivity disorder: a systematic review of qualitative research. Child and Adolescent Mental Health. 2019;24(2):113-122. https://doi.org/10.1111/camh.12297
Claim-to-source matrix
What each source supports
Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.
| Claim group | Sources | Years | Used in | Limitation |
|---|---|---|---|---|
| State-level variation in childhood ADHD diagnosis, medication use and behavioral treatment | [13] | 2022 | Current evidence | Parent-reported national survey data for 2016 to 2019; state estimates rather than health-system data. |
| Rising self-reported adult ADHD diagnosis and its demographic variation | [6] | 2025 | Current evidence | Self-report from an online panel survey of adults aged 18 to 64; the authors describe the estimates as provisional. |
| Injury risk among children with ADHD | [11] | 2023 | Current evidence | Cross-sectional survey data from 2010 to 2019; association only, mechanisms not examined. |
| Medication shortages and shifts in dispensing to maintain continuity | [7] | 2025 | Current evidence | Aggregate Australian dispensing data for one medicine; no patient-level outcomes. |
| Child-to-adult service transition rates and drop-off at referral acceptance and first appointment | [14] | 2020 | Continuum of care | British surveillance limited to young people taking medication; estimates are a lower limit of transition need. |
| Young people’s, carers’ and clinicians’ experiences of transition | [15] | 2019 | Continuum of care | Eight qualitative studies, six from the United Kingdom, published up to January 2017. |
| Treatment use, satisfaction and reasons for not using care among children and adolescents | [5] | 2025 | Continuum of care | Parent survey within one German insured population with administrative diagnoses. |
| Lived experience of the prescription stimulant shortage | [8] | 2025 | Continuum of care | Qualitative interview study; the abstract reports no sample size or setting. |
| Adult ADHD treatment capacity among telepsychology providers | [3] | 2026 | Access | Public directory listings from April 2025; listings may not reflect actual practice. |
| Specialist constraints and the role of primary care in adult ADHD | [9] | 2024 | Access | Cross-sectional surveys in England with convenience samples of health professionals and people with lived experience; provision was self-reported and varied by NHS region. |
| Barriers, delays and post-diagnosis support in adult diagnosis | [1] | 2026 | Access | Thematic synthesis of 21 studies; no pooled estimates. |
| Race, insurance, shared decision making and medication receipt | [12] | 2023 | Equity and trust | Seven-caregiver case study plus secondary analysis limited to 450 Black uninsured or publicly insured children. |
| Experiences of women diagnosed with ADHD in adulthood | [10] | 2023 | Equity and trust | Eight studies synthesized thematically; no quantitative estimates. |
| Primary care coordination with schools and differentiated training needs | [2] | 2026 | Human infrastructure | Self-reported provider survey from fall 2023; measures the level of coordination, not its quality or outcomes. |
| Quality of ADHD content on social media and viewer self-identification | [4] | 2025 | Public communication | The 125 most-liked videos on one platform; comment analysis drawn from six videos. |

About the author
Greg Wahlstrom
MBAHCM
President and Chief Executive Officer, The Healthcare Executive
View Greg’s profile©2014 – 2026 The Healthcare Executive. All rights reserved.

